Aix Marseille Univ, Inserm, U1251-MMG, Marseille Medical Genetics, Marseille, France.
APHM, Hôpital Timone Enfants, Département de Génétique Médicale, Marseille, France.
Neuropathol Appl Neurobiol. 2020 Oct;46(6):564-578. doi: 10.1111/nan.12624. Epub 2020 Jun 10.
The most common autosomal recessive limb girdle muscular dystrophy is associated with the CAPN3 gene. The exclusively recessive inheritance of this disorder has been recently challenged by the description of the recurrent variants, c.643_663del21 [p.(Ser215_Gly221del)] and c.598_612del15 [p.(Phe200_Leu204del)], associated with autosomal dominant inheritance. Our objective was to confirm the existence of autosomal dominant calpainopathies.
Through our activity as one of the reference centres for genetic diagnosis of calpainopathies in France and the resulting collaborations through the French National Network for Rare Neuromuscular Diseases (FILNEMUS), we identified four families harbouring the same CAPN3 heterozygous variant with supposedly autosomal dominant inheritance.
We identified a novel dominantly inherited CAPN3 variant, c.1333G>A [p.(Gly445Arg)] in 14 affected patients from four unrelated families. The complementary phenotypic, functional and genetic findings correlate with an autosomal dominant inheritance in these families, emphasizing the existence of this novel transmission mode for calpainopathies. The mild phenotype associated with these autosomal dominant cases widens the phenotypic spectrum of calpainopathies and should therefore be considered in clinical practice.
We confirm the existence of autosomal dominant calpainopathies as an entity beyond the cases related to the in-frame deletions c.643_663del21 and c.598_612del15, with the identification of a novel dominantly inherited and well-documented CAPN3 missense variant, c.1333G>A [p.(Gly445Arg)]. In addition to the consequences for genetic counselling, the confirmation of an autosomal dominant transmission mode for calpainopathies underlines the importance of re-assessing other myopathies for which the inheritance is considered as strictly autosomal recessive.
最常见的常染色体隐性肢带型肌营养不良症与 CAPN3 基因有关。这种疾病的纯隐性遗传最近受到挑战,因为描述了重复出现的变体 c.643_663del21 [p.(Ser215_Gly221del)] 和 c.598_612del15 [p.(Phe200_Leu204del)],它们与常染色体显性遗传有关。我们的目标是确认是否存在常染色体显性钙蛋白酶病。
通过我们作为法国钙蛋白酶病基因诊断参考中心之一的活动,以及由此产生的通过法国罕见神经肌肉疾病网络(FILNEMUS)的合作,我们确定了四个携带相同 CAPN3 杂合变体的家族,这些变体具有常染色体显性遗传。
我们在四个无关家族的 14 名受影响患者中发现了一种新的显性遗传 CAPN3 变体 c.1333G>A [p.(Gly445Arg)]。这些家族的互补表型、功能和遗传发现与常染色体显性遗传相关,强调了钙蛋白酶病存在这种新的传递模式。这些常染色体显性病例的轻度表型扩大了钙蛋白酶病的表型谱,因此在临床实践中应考虑这种表型。
我们确认了常染色体显性钙蛋白酶病的存在,这是一种与框架内缺失 c.643_663del21 和 c.598_612del15 无关的实体,同时还发现了一种新的显性遗传且有充分记录的 CAPN3 错义变体 c.1333G>A [p.(Gly445Arg)]。除了对遗传咨询的影响外,钙蛋白酶病的常染色体显性传递模式的确认强调了重新评估其他被认为是纯常染色体隐性遗传的肌病的重要性。